CYTK logo

CYTK EBITDA

annual EBITDA:

-$493.48M-$36.80M(-8.06%)
December 31, 2024

Summary

  • As of today (June 20, 2025), CYTK annual EBITDA is -$493.48 million, with the most recent change of -$36.80 million (-8.06%) on December 31, 2024.
  • During the last 3 years, CYTK annual EBITDA has fallen by -$309.78 million (-168.63%).
  • CYTK annual EBITDA is now -1919.36% below its all-time high of $27.12 million, reached on December 31, 2009.

Performance

CYTK EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCYTKincome statement metrics

quarterly EBITDA:

-$136.13M-$11.09M(-8.87%)
March 1, 2025

Summary

  • As of today (June 20, 2025), CYTK quarterly EBITDA is -$136.13 million, with the most recent change of -$11.09 million (-8.87%) on March 1, 2025.
  • Over the past year, CYTK quarterly EBITDA has dropped by -$20.14 million (-17.36%).
  • CYTK quarterly EBITDA is now -340.59% below its all-time high of $56.58 million, reached on June 30, 2009.

Performance

CYTK quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCYTKincome statement metrics

TTM EBITDA:

-$513.62M-$20.14M(-4.08%)
March 1, 2025

Summary

  • As of today (June 20, 2025), CYTK TTM EBITDA is -$513.62 million, with the most recent change of -$20.14 million (-4.08%) on March 1, 2025.
  • Over the past year, CYTK TTM EBITDA has dropped by -$57.15 million (-12.52%).
  • CYTK TTM EBITDA is now -1868.49% below its all-time high of $29.04 million, reached on September 30, 2009.

Performance

CYTK TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCYTKincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CYTK EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.1%-17.4%-12.5%
3 y3 years-168.6%-72.8%-130.6%
5 y5 years-430.4%-362.8%-416.9%

CYTK EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-168.6%at low-1482.3%at low-189.8%at low
5 y5-year-468.6%at low-2102.5%at low-583.4%at low
alltimeall time-1919.4%at low-340.6%at low-1868.5%at low

CYTK EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$136.13M(+8.9%)
-$513.62M(+4.1%)
Dec 2024
-$493.48M(+8.1%)
-$125.04M(-7.9%)
-$493.48M(+2.4%)
Sep 2024
-
-$135.84M(+16.5%)
-$481.94M(+4.8%)
Jun 2024
-
-$116.61M(+0.5%)
-$459.67M(+0.7%)
Mar 2024
-
-$115.99M(+2.2%)
-$456.48M(-0.0%)
Dec 2023
-$456.68M(+37.6%)
-$113.50M(-0.1%)
-$456.68M(-1.3%)
Sep 2023
-
-$113.57M(+0.1%)
-$462.64M(-2.4%)
Jun 2023
-
-$113.42M(-2.4%)
-$474.20M(+28.4%)
Mar 2023
-
-$116.20M(-2.7%)
-$369.39M(+11.3%)
Dec 2022
-$331.99M(+80.7%)
-$119.45M(-4.5%)
-$331.99M(+41.9%)
Sep 2022
-
-$125.14M(+1354.6%)
-$233.88M(+31.9%)
Jun 2022
-
-$8.60M(-89.1%)
-$177.25M(-20.4%)
Mar 2022
-
-$78.79M(+269.1%)
-$222.72M(+21.2%)
Dec 2021
-$183.71M(+111.7%)
-$21.35M(-68.8%)
-$183.71M(-6.3%)
Sep 2021
-
-$68.51M(+26.7%)
-$195.97M(+62.4%)
Jun 2021
-
-$54.07M(+35.9%)
-$120.66M(+24.2%)
Mar 2021
-
-$39.78M(+18.4%)
-$97.15M(+11.9%)
Dec 2020
-$86.78M(-6.7%)
-$33.61M(-594.4%)
-$86.78M(+15.5%)
Sep 2020
-
$6.80M(-122.2%)
-$75.16M(-28.1%)
Jun 2020
-
-$30.56M(+3.9%)
-$104.53M(+5.2%)
Mar 2020
-
-$29.41M(+33.8%)
-$99.36M(+6.8%)
Dec 2019
-$93.04M(+11.4%)
-$21.98M(-2.6%)
-$93.04M(+1.6%)
Sep 2019
-
-$22.57M(-11.1%)
-$91.61M(+7.3%)
Jun 2019
-
-$25.39M(+10.0%)
-$85.36M(+4.6%)
Mar 2019
-
-$23.09M(+12.3%)
-$81.64M(-1.8%)
Dec 2018
-$83.49M(-23.3%)
-$20.56M(+25.9%)
-$83.17M(-14.9%)
Sep 2018
-
-$16.32M(-24.7%)
-$97.75M(-10.0%)
Jun 2018
-
-$21.67M(-12.0%)
-$108.62M(-2.2%)
Mar 2018
-
-$24.62M(-30.0%)
-$111.10M(+2.0%)
Dec 2017
-$108.87M(-647.3%)
-$35.14M(+29.2%)
-$108.88M(+65.9%)
Sep 2017
-
-$27.20M(+12.6%)
-$65.64M(+1466.5%)
Jun 2017
-
-$24.14M(+7.8%)
-$4.19M(-145.4%)
Mar 2017
-
-$22.39M(-376.7%)
$9.22M(-53.7%)
Dec 2016
$19.89M(-154.3%)
$8.09M(-76.4%)
$19.89M(+565.9%)
Sep 2016
-
$34.25M(-419.1%)
$2.99M(-107.5%)
Jun 2016
-
-$10.73M(-8.4%)
-$39.97M(+0.7%)
Mar 2016
-
-$11.72M(+33.1%)
-$39.68M(+8.1%)
Dec 2015
-$36.64M(+158.9%)
-$8.81M(+1.2%)
-$36.72M(+90.8%)
Sep 2015
-
-$8.70M(-16.7%)
-$19.24M(+17.2%)
Jun 2015
-
-$10.44M(+19.1%)
-$16.41M(+15.1%)
Mar 2015
-
-$8.76M(-201.1%)
-$14.26M(+0.7%)
Dec 2014
-$14.16M(-57.5%)
$8.67M(-247.6%)
-$14.16M(-12.2%)
Sep 2014
-
-$5.87M(-29.1%)
-$16.13M(-29.2%)
Jun 2014
-
-$8.29M(-4.4%)
-$22.76M(-22.6%)
Mar 2014
-
-$8.66M(-229.4%)
-$29.43M(-11.6%)
Dec 2013
-$33.28M
$6.70M(-153.5%)
-$33.28M(-35.1%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$12.51M(-16.3%)
-$51.31M(+5.4%)
Jun 2013
-
-$14.95M(+19.4%)
-$48.70M(+14.4%)
Mar 2013
-
-$12.52M(+10.6%)
-$42.58M(+7.0%)
Dec 2012
-$39.78M(-14.5%)
-$11.33M(+14.4%)
-$39.80M(-0.8%)
Sep 2012
-
-$9.90M(+12.2%)
-$40.12M(-1.2%)
Jun 2012
-
-$8.82M(-9.5%)
-$40.59M(-9.8%)
Mar 2012
-
-$9.75M(-16.3%)
-$45.00M(-3.3%)
Dec 2011
-$46.52M(-1.8%)
-$11.64M(+12.2%)
-$46.52M(+1.1%)
Sep 2011
-
-$10.38M(-21.6%)
-$46.01M(-3.5%)
Jun 2011
-
-$13.23M(+17.3%)
-$47.66M(+1.3%)
Mar 2011
-
-$11.27M(+1.3%)
-$47.04M(-0.8%)
Dec 2010
-$47.40M(-274.8%)
-$11.13M(-7.5%)
-$47.40M(-1.4%)
Sep 2010
-
-$12.03M(-4.5%)
-$48.06M(+10.2%)
Jun 2010
-
-$12.61M(+8.4%)
-$43.63M(-270.7%)
Mar 2010
-
-$11.63M(-1.4%)
$25.56M(-5.8%)
Dec 2009
$27.12M(-150.8%)
-$11.79M(+55.3%)
$27.12M(-6.6%)
Sep 2009
-
-$7.59M(-113.4%)
$29.04M(+26.1%)
Jun 2009
-
$56.58M(-661.9%)
$23.04M(-147.1%)
Mar 2009
-
-$10.07M(+2.0%)
-$48.95M(-8.4%)
Dec 2008
-$53.43M(-0.4%)
-$9.87M(-27.4%)
-$53.43M(-7.7%)
Sep 2008
-
-$13.60M(-11.7%)
-$57.85M(+1.9%)
Jun 2008
-
-$15.40M(+5.8%)
-$56.78M(+2.9%)
Mar 2008
-
-$14.55M(+1.8%)
-$55.20M(+2.9%)
Dec 2007
-$53.66M(-8.1%)
-$14.30M(+14.1%)
-$53.66M(-3.6%)
Sep 2007
-
-$12.53M(-9.3%)
-$55.63M(-4.7%)
Jun 2007
-
-$13.82M(+6.2%)
-$58.38M(-0.6%)
Mar 2007
-
-$13.01M(-20.1%)
-$58.70M(+0.5%)
Dec 2006
-$58.41M(+40.5%)
-$16.27M(+6.5%)
-$58.41M(+10.0%)
Sep 2006
-
-$15.28M(+8.0%)
-$53.09M(+11.1%)
Jun 2006
-
-$14.14M(+11.2%)
-$47.78M(+8.7%)
Mar 2006
-
-$12.72M(+16.1%)
-$43.97M(+5.8%)
Dec 2005
-$41.57M(+18.2%)
-$10.95M(+9.9%)
-$41.57M(-1.2%)
Sep 2005
-
-$9.97M(-3.5%)
-$42.09M(+0.3%)
Jun 2005
-
-$10.33M(+0.1%)
-$41.95M(+4.0%)
Mar 2005
-
-$10.32M(-10.1%)
-$40.33M(+14.7%)
Dec 2004
-$35.16M(+19.5%)
-$11.47M(+16.7%)
-$35.16M(-45.2%)
Sep 2004
-
-$9.83M(+12.9%)
-$64.21M(+24.1%)
Jun 2004
-
-$8.71M(+69.1%)
-$51.73M(+8.3%)
Mar 2004
-
-$5.15M(-87.3%)
-$47.76M(+0.3%)
Dec 2003
-$29.41M(+39.2%)
-$40.52M(-1632.6%)
-$47.62M(+571.1%)
Sep 2003
-
$2.64M(-155.9%)
-$7.09M(-27.1%)
Jun 2003
-
-$4.73M(-5.5%)
-$9.74M(+94.5%)
Mar 2003
-
-$5.01M
-$5.01M
Dec 2002
-$21.13M(+14.9%)
-
-
Dec 2001
-$18.39M(+33.3%)
-
-
Dec 2000
-$13.79M
-
-

FAQ

  • What is Cytokinetics Incorporated annual EBITDA?
  • What is the all time high annual EBITDA for Cytokinetics Incorporated?
  • What is Cytokinetics Incorporated annual EBITDA year-on-year change?
  • What is Cytokinetics Incorporated quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cytokinetics Incorporated?
  • What is Cytokinetics Incorporated quarterly EBITDA year-on-year change?
  • What is Cytokinetics Incorporated TTM EBITDA?
  • What is the all time high TTM EBITDA for Cytokinetics Incorporated?
  • What is Cytokinetics Incorporated TTM EBITDA year-on-year change?

What is Cytokinetics Incorporated annual EBITDA?

The current annual EBITDA of CYTK is -$493.48M

What is the all time high annual EBITDA for Cytokinetics Incorporated?

Cytokinetics Incorporated all-time high annual EBITDA is $27.12M

What is Cytokinetics Incorporated annual EBITDA year-on-year change?

Over the past year, CYTK annual EBITDA has changed by -$36.80M (-8.06%)

What is Cytokinetics Incorporated quarterly EBITDA?

The current quarterly EBITDA of CYTK is -$136.13M

What is the all time high quarterly EBITDA for Cytokinetics Incorporated?

Cytokinetics Incorporated all-time high quarterly EBITDA is $56.58M

What is Cytokinetics Incorporated quarterly EBITDA year-on-year change?

Over the past year, CYTK quarterly EBITDA has changed by -$20.14M (-17.36%)

What is Cytokinetics Incorporated TTM EBITDA?

The current TTM EBITDA of CYTK is -$513.62M

What is the all time high TTM EBITDA for Cytokinetics Incorporated?

Cytokinetics Incorporated all-time high TTM EBITDA is $29.04M

What is Cytokinetics Incorporated TTM EBITDA year-on-year change?

Over the past year, CYTK TTM EBITDA has changed by -$57.15M (-12.52%)
On this page